On this episode of Stock Movers:


- IAG announced a major order for widebody jets, doubling down on a long-haul business with a $10 billion fleet investment to help sustain its earnings momentum.

 
- Campari shares fall as much as 4.6% after the Italian spirits maker’s first-quarter results missed expectations, showing that the backdrop continues to be tough with analysts flagging an uncertain outlook due to trade tensions.

- Bloomberg reported that Shell has been studying the merits of acquiring BP — something both companies have so far declined to comment on — analysts have been gaming out both the upsides and downsides.

On this episode of Stock Movers:
 - IAG announced a major order for widebody jets, doubling down on a long-haul business with a $10 billion fleet investment to help sustain its earnings momentum.
&nbsp; - Campari shares fall as much as 4.6% after the Italian spirits maker&rsquo;s first-quarter results missed expectations, showing that the backdrop continues to be tough with analysts flagging an uncertain outlook due to trade tensions. - Bloomberg reported that Shell has been studying the merits of acquiring BP &mdash; something both companies have so far declined to comment on &mdash; analysts have been gaming out both the upsides and downsides.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. 

Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Listen for five-minute conversations on today's biggest winners and losers in the stock market.&nbsp;
Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Listen for news on today's biggest winners and losers in the stock market.

Stock Movers

IAG Orders, Campari Down, BP M&A Target

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/27b7a8c3-c259-41f8-ad80-b2d80089034b/transcript

Today's biggest winners and losers in the stock market.

On this episode of Stock Movers, we take a look at some of the biggest gainers and decliners from the past week: 

- CF Industries (CF) saw its shares trade higher this week, along with other stocks in the chemical and fertilizer space. Fertilizer markets are tightening as the escalating conflict in the Middle East threatens global supplies of nitrogen-based crop nutrients, boosting companies such as CF Industries Holdings Inc., the world’s largest producer of ammonia. CF Industries shares rose as much as 14% on Thursday, the biggest intraday jump since 2020 and to a record high. The Illinois-based company controls nearly 40% of the North American nitrogen fertilizer market, while Nutrien (NTR) — which climbed 7.6% to the highest price in more than three years — controls another 22%.

- Centene (CNC) shares sank on Tuesday after the health insurer flagged rising medical costs and declining membership, adding to an already cautious outlook for the industry. Centene said it expects enrollment in the Affordable Care Act marketplace will decline by about 35% or more across the industry after some federal ACA subsidies expired. It sees its own membership potentially dropping even faster. The company’s membership dropped from 5.5 million in December to 3.6 million in February, a decline that CEO Sarah London said was “in line with our expectations.” 

- Hims & Hers (HIMS) shares posted their best week on record as a new partnership with Novo Nordisk A/S fuels fresh optimism about the company’s future in weight-loss drugs. The San Francisco-based company’s stock climbed about 57% this week, rallying in four of the past five trading sessions. Earlier this week, the telehealth company said it would work with Novo to sell blockbusters Ozempic and Wegovy on its platform, ending a feud between the firms. Novo also agreed to drop a lawsuit it filed against Hims last month. In return, Hims will no longer advertise compounded versions of Novo’s drugs, but it will still sell copies of Ozempic and Wegovy if a doctor says a patient needs them. 

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers, we take a look at some of the biggest gainers and decliners from the past week:&nbsp;
- CF Industries (CF) saw its shares trade higher this week, along with other stocks in the chemical and fertilizer space. Fertilizer markets are tightening as the escalating conflict in the Middle East threatens global supplies of nitrogen-based crop nutrients, boosting companies such as CF Industries Holdings Inc., the world&rsquo;s largest producer of ammonia. CF Industries shares rose as much as 14% on Thursday, the biggest intraday jump since 2020 and to a record high. The Illinois-based company controls nearly 40% of the North American nitrogen fertilizer market, while Nutrien (NTR) &mdash; which climbed 7.6% to the highest price in more than three years &mdash; controls another 22%.
- Centene (CNC) shares sank on Tuesday after the health insurer flagged rising medical costs and declining membership, adding to an already cautious outlook for the industry. Centene said it expects enrollment in the Affordable Care Act marketplace will decline by about 35% or more across the industry after some federal ACA subsidies expired. It sees its own membership potentially dropping even faster. The company&rsquo;s membership dropped from 5.5 million in December to 3.6 million in February, a decline that CEO Sarah London said was &ldquo;in line with our expectations.&rdquo;&nbsp;
- Hims &amp; Hers (HIMS) shares posted their best week on record as a new partnership with Novo Nordisk A/S fuels fresh optimism about the company&rsquo;s future in weight-loss drugs. The San Francisco-based company&rsquo;s stock climbed about 57% this week, rallying in four of the past five trading sessions. Earlier this week, the telehealth company said it would work with Novo to sell blockbusters Ozempic and Wegovy on its platform, ending a feud between the firms. Novo also agreed to drop a lawsuit it filed against Hims last month. In return, Hims will no longer advertise compounded versions of Novo&rsquo;s drugs, but it will still sell copies of Ozempic and Wegovy if a doctor says a patient needs them.&nbsp;

Weekly Roundup: CF Industries Rises, Centene Sinks, Hims & Hers Skyrockets

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/4245a70d-9a0a-4cdf-9d90-b40d014d87d8/transcript

Today's biggest winners and losers in the stock market.

On this episode of Stock Movers:

- Meta Platforms (META) shares fell after the New York Times reported that Meta would delay the rollout of a new A.I. model after it had performance concerns

- Adobe (ADBE) stocks plunged after Chief Executive Officer Shantanu Narayen announced he will resign from his position atop the creative software giant amid deep skepticism about the company’s ability to thrive in the AI era.

- Ulta Beauty (ULTA) shares dropped after the cosmetics retailer reported earnings per share for the fourth quarter that missed consensus. Analysts flag that the full-year forecast was disappointing, while Morgan Stanley notes that the guidance might be conservative. 

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Meta Platforms (META) shares fell after the New York Times reported that Meta would delay the rollout of a new A.I. model after it had performance concerns
- Adobe (ADBE) stocks plunged after Chief Executive Officer Shantanu Narayen announced he will resign from his position atop the creative software giant amid deep skepticism about the company&rsquo;s ability to thrive in the AI era.
- Ulta Beauty (ULTA) shares dropped after the cosmetics retailer reported earnings per share for the fourth quarter that missed consensus. Analysts flag that the full-year forecast was disappointing, while Morgan Stanley notes that the guidance might be conservative.&nbsp;

Meta Platforms, Adobe and Ulta Beauty Plunge

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/36f741ff-c123-4084-a3c9-b40c01386787/transcript

On this episode of Stock Movers:

- Adobe (ADBE) shares fall after news that Chief Executive Officer Shantanu Narayen will resign from his position amid deep skepticism about the company’s ability to thrive in the AI era.

- Peloton (PTON) shares drop after news the company is planning to make treadmills a larger priority and is considering lower-priced versions, according to people with knowledge of the matter.

- Hims & Hers Health (HIMS) shares are mixed. Shares are on pace for their best week on record as a new partnership with Novo Nordisk A/S fuels fresh optimism about the company’s future in weight-loss drugs. The San Francisco-based company’s stock has climbed about 51% so far this week, as of Thursday’s close.

On this episode of Stock Movers:
- Adobe (ADBE) shares fall after news that Chief Executive Officer Shantanu Narayen will resign from his position amid deep skepticism about the company&rsquo;s ability to thrive in the AI era.
- Peloton (PTON) shares drop after news the company is planning to make treadmills a larger priority and is considering lower-priced versions, according to people with knowledge of the matter.
- Hims &amp; Hers Health (HIMS) shares are mixed. Shares are on pace for their best week on record as a new partnership with Novo Nordisk A/S fuels fresh optimism about the company&rsquo;s future in weight-loss drugs. The San Francisco-based company&rsquo;s stock has climbed about 51% so far this week, as of Thursday&rsquo;s close.

 Adobe Falls, Peloton Drops, Hims & Hers Health Mixed As Shares Set for Record Week

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/de5e568d-5508-4707-a81f-b40c00fa8d64/transcript

IAG Orders, Campari Down, BP M&A Target

In 1 playlist(s)

Stock Movers

Social links

Follow podcast

Recent clips